Lipocine Announces Last Patient Completes Final Study Visit In Phase 3 Clinical Trial For Oral Post-Partum Depression Treatment Brexanolone

Lipocine Inc +10.85% Post

Lipocine Inc

LPCN

8.99

9.15

+10.85%

+1.78% Post
Lipocine Announces Last Patient Completes Final Study Visit In Phase 3 Clinical Trial For Oral Post-Partum Depression Treatment Brexanolone
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via